Skip to Main Content

Paper Details

Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIV.
AIDS
2
2023
AIDS-defining illness, ASCVD, CD4 +, CD4 + T-cell, HIV, HIV-1 RNA, Hepatic steatosis, LpPLA-2, Metabolic syndrome, NAFLD, PWH, Steatosis, alcohol use, atherosclerotic cardiovascular disease, cardiovascular disease, cholesterol, hepatic steatosis, high-density lipoprotein cholesterol, hs-CRP, men, metabolic syndrome, nonalcoholic fatty liver disease, participants, people, persons, pitavastatin calcium, steatosis, viral hepatitis
Author NameAffiliation
Heather J RibaudoHarvard University
Pamela S DouglasDuke University
Carl J FichtenbaumUniversity of Cincinnati
  • 1 - 3

Datasets

Release 1.2